Cannabis Law Report

JANUARY 4, 2022

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. Our lead product, ANEB-001, has the potential to rapidly reverse the effects of acute cannabinoid intoxication, a relatively unknown yet serious affliction that sends more than 5,000 Americans to the hospital emergency department every day.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Cannabinoids 52

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. Zambon is a multinational pharmaceutical company that focuses on innovation and development with the aim to improve patients’ lives. The market for medical cannabis in Germany.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Cannabis Law Report

JUNE 1, 2022

This acquisition will accelerate Khiron’s growth in Europe by controlling the complete value chain for its products and gaining direct access to German pharmacies. Pharmadrug GmbH has been active worldwide for almost 40 years as a manufacturer and wholesaler of medicinal products and active pharmaceutical ingredients.

Pharmaceutical 52

Pharmaceutical Medicine Extraction Cannabinoids 52

MMJ Recs

APRIL 1, 2024

CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions. From its anti-inflammatory properties to its ability to alleviate pain, CBD shows promise in addressing various health conditions.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. Epidyolex has been approved as a treatment option for children as young as two with Lennox-Gastaut syndrome or Dravet syndrome – difficult-to-treat conditions that can cause multiple seizures a day. ” Source BBC: [link].

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Veriheal

AUGUST 9, 2023

Recent research reaffirms earlier studies that claim that certain non-marijuana plants contain similar compounds found in cannabis, often called cannabinoids. Even more, CBD is the first FDA-approved pharmaceutical drug for two rare forms of epileptic seizures in kids.

CBD 93

CBD Cannabinoids THC Extraction 93

Cannabis Law Report

DECEMBER 1, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, today announced that it will participate in two investor conferences during the month of December 2021. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Therapy 52

Veriheal

SEPTEMBER 27, 2021

The United Kingdom’s Multiple Sclerosis (MS) Society has taken a stand against restricted access to medical cannabis in the country. Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? Yet many people with MS are still unable to access it.”

Treatment 98

Treatment Patients Access Research and Development 98

MMJ Recs

FEBRUARY 18, 2024

This comprehensive article aims to explore the myriad health benefits of medical marijuana, delving into its therapeutic potential, impact on mental health, role in managing chronic conditions, and the holistic healing it offers, with a special focus on cannabinoids like CBD.

Chronic Pain 52

Chronic Pain Marijuana Epilepsy Research and Development 52

Veriheal

OCTOBER 13, 2020

Ulcerative Colitis is a condition that causes long-lasting inflammation and ulcers (sores) in the innermost lining of the individual’s large intestine and rectum. Crohn’s Disease is also a condition that causes inflammation, but it affects the lining of the digestive tract, which can then spread deeply into the affected tissues. .

Digestion 123

Digestion Treatment Conditions Research and Development 123

Cannabis Law Report

SEPTEMBER 8, 2021

Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘).

Access 97

Access Research and Development Medicine THC 97

PrestoDoctor

SEPTEMBER 6, 2023

Traditionally, prescription codeine has been prescribed for a variety of conditions, including post-operative pain, dental procedures, and chronic pain. The plant’s active compounds, cannabinoids, interact with the body’s endocannabinoid system, which plays a crucial role in regulating pain perception.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

United Patients Group

MAY 17, 2023

Introduction Autism spectrum disorder (ASD) is a neurodevelopmental condition that affects communication, social interactions and behaviors. Some researchers believe that cannabinoids may help people with ASD manage anxiety and stress by increasing their ability to focus and pay attention.

Sleep 80

Sleep Cannabinoids Patients CBD 80

Veriheal

AUGUST 13, 2020

In talking about cannabis and its uses, a lot of attention is always paid to THC, the most well known cannabinoid in the cannabis plant. CBD is a non-intoxicating cannabinoid that offers many of the same medical benefits as THC. Just a few months ago, Dr. Mechoulam discovered an all-new cannabinoid previously unknown to anyone.

Cannabinoids 98

Cannabinoids Chronic Pain Sleep Pharmaceutical 98

The Cannigma

JANUARY 21, 2021

CBG (cannabigerol) is by far one of the most important cannabinoids in the cannabis plant. It is often called “the mother of all cannabinoids,” and it holds potential as a treatment for conditions such as diabetes, ALS, and Huntington’s disease, although human studies are seriously lacking. CBG vs CBD.

Research and Development 145

Research and Development Blood Pressure Conditions Cannabinoids 145

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

It seems like the medical research community remains largely divided on the issue, with some insisting that cannabis use contributes to mental health condition diagnoses while others suggesting that people with mental health conditions are inherently drawn to cannabis use. CBD for Anxiety.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

The Cannigma

FEBRUARY 4, 2021

When it comes to cannabis and the struggle for legalization, improving access, and changing hearts and minds, advocates often find themselves up against decades-old myths, misconceptions, and stereotypes that have been delivered from authoritative sources for so long that for many people they supplant the truth. No-go, say the Feds.

THC 145

THC Cannabinoids Blood Pressure Conditions 145

The Cannigma

JUNE 2, 2022

Ever wondered how cannabinoids like THC or CBD affect your blood? The short answer is – no, in most cases cannabinoids do not seem to act as strong blood thinners. In this study the authors speculated that cannabinoids may be inhibiting an enzyme in blood plasma called thrombin, which promotes blood clotting.

Blood Pressure 112

Blood Pressure Cannabinoids Patients THC 112

MJ Business Attorneys

JUNE 29, 2018

The FDA approved Epidiolex as a prescription drug to be used to treat two severe epileptic conditions, Lennox-Gastaut syndrome and Dravet syndrome. DEA, the DEA expressed in their brief that they do not wish to control cannabinoids, but rather only those cannabinoids derived from the flowers and resins of a cannabis plant above.3%

DEA 113

DEA CBD Pharmaceutical Research and Development 113

Cannabis Law Report

OCTOBER 26, 2021

Following this selection, Tilray will supply a variety of its pharmaceutical-grade medical cannabis products, including extracts and dried flower with different degrees of THC and CBD for patients with varying medical conditions.

Pharmaceutical 52

Pharmaceutical Research and Development Patients Access 52

The Cannigma

MAY 13, 2022

CBDA is a less studied cannabinoid but it is beginning to gain attention for its potential medical uses for a variety of applications including pain, inflammation, cancer, and COVID-19. While other cannabinoids can also help with some of these issues, CBDA has shown special promise for some of the more debilitating conditions on the list.

Tincture 115

Tincture Cannabinoids Strains CBD 115

Veriheal

MAY 17, 2021

Other states have gone beyond just medical access and have also legalized retail cannabis markets for adult consumers. Please don’t further the lie by voting for any form of legalization beyond the pharmaceutical remedies already available under state law.” ” State Doctors Oppose Legalization in Alabama.

Legalization 86

Legalization Pharmaceutical Therapy Chronic Pain 86

PrestoDoctor

OCTOBER 13, 2023

Marinol, also known as Dronabinol, is a medication used to treat a variety of conditions, including nausea and vomiting caused by chemotherapy, loss of appetite and weight loss in people with HIV/AIDS, as well as chronic pain. However, unlike marijuana, Marinol is a FDA-approved pharmaceutical drug.

THC 98

THC Chronic Pain Treatment Conditions 98

Cannabis Law Report

SEPTEMBER 14, 2022

Although a limited number of people have been able to access it via the Peer Approved Clinical System (PACS) Tier 2 individual patient treatment request process. Sativex , which is administered via a mouth spray, contains the cannabinoids CBD and THC.

Treatment 52

Treatment Access Patients Medicine 52

MMJ Recs

JANUARY 17, 2024

The cannabinoids found in cannabis, particularly cannabidiol (CBD) and tetrahydrocannabinol (THC), have demonstrated potent anti-inflammatory and analgesic properties. Patients need to have a documented medical condition, such as arthritis, that falls within the state’s approved list of qualifying conditions.

Strains 98

Strains Marijuana Indica Microdosing 98

Cannabis Law Report

NOVEMBER 30, 2021

LONDON–(BUSINESS WIRE)– #cannabinoids –Óskare Capital is proud to announce the launch of the first ever SEIS and EIS fund targeting the Medical and Pharmaceutical Cannabis sector. The Fund aims to provide UK retail investors with access to a diversified portfolio of companies in this rapidly growing sector.

Pharmaceutical 52

Pharmaceutical Cannabinoids Epilepsy Sleep 52

Canna Care Docs

SEPTEMBER 18, 2020

To prepare for your appointment you will want to collect your medical records about the condition you wish to treat with medical cannabis. This can be as simple as taking a picture of a prescription bottle you have been given to treat your condition. What Conditions Qualify for Medical Marijuana Cards in Virginia?

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

Veriheal

SEPTEMBER 23, 2021

Despite growing evidence that cannabinoid therapies hold promise for treating many conditions, current federal laws and the stigma driving them continue to make it difficult for cannabis businesses to find affordable insurance plans. Current Insurance Options Are Costly and Limited.

Business 97

Business Access Cannabis Therapy 97

PrestoDoctor

JUNE 7, 2023

A migraine is a neurological condition that presents intense, throbbing pain and headaches. Marijuana strains with the right combination of cannabinoids show potential. This offers a natural, sustainable relief in place of pharmaceutical options like opioids or other medications. What Is A Migraine?

Research and Development 52

Research and Development Indica Strains Sleep 52

MMJ Recs

JANUARY 22, 2024

This nuanced approach allows patients to customize their treatment, addressing specific symptoms or conditions without compromising mental clarity. CBD edibles, ranging from gummies to infused snacks, provide a discreet and precisely dosed method for individuals seeking relief from conditions such as anxiety, chronic pain, and insomnia.

Edibles 52

Edibles Marijuana Chronic Pain THC 52

The Cannigma

JUNE 1, 2021

Patients can take part if they have a medical condition which has not responded to pharmaceutical drugs. Some of the qualifying health conditions include epilepsy, neuropathic pain, chemotherapy side effects, a need for palliative care, and pain linked to multiple sclerosis, according to France24.

Law 113

Law Epilepsy Programs Patients 113

Cannabis Law Report

JUNE 7, 2019

The use of pharmaceutical cannabinoid products in Singapore comes under strict frameworks and regulations and does not diminish the country’s zero-tolerance position against drugs, the Home Affairs and Health ministries have said. Cannabinoids are chemical compounds found in the cannabis plant. The Straits Times Reports.

Pharmaceutical 40

Pharmaceutical Cannabinoids Safety Data 40

Veriheal

AUGUST 2, 2023

While some studies show that cannabis increases creativity, others have concluded that cannabis doesn’t increase creativity but rather allows you to be open-minded enough to access and utilize the creativity that you already possess. Many conditions, as we are seeing today, can be effectively managed with cannabinoid therapies.

Microdosing 98

Microdosing Consumption Pharmaceutical Cannabis 98

Leaf Science

JULY 23, 2019

In spite of this, research has shown that THC as much as the other cannabinoids present in cannabis has medicinal value to humans. In the UK, cannabis was legalized for medicinal purposes in 2018 which saw patients of epilepsy and multiple sclerosis able to access pharmaceutical cannabis derivatives such as Sativex and Epidiolex.

Strains 74

Strains Cannabinoids Epilepsy THC 74

Cannabis Info

MARCH 2, 2019

Epilepsy is a neurological condition, that directly affects the nervous system and causes seizures in individuals who suffer from the condition. However, the most common attempt at treating the condition is through medication, many patients may need to take them for the rest of their life. WHAT EXACTLY IS EPILEPSY? CASE STUDY.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

The Cannigma

APRIL 12, 2023

CBN has made headlines and claimed shelf space as the next best cannabinoid for sleep. Cannabis is often reported to help people reduce the number of pharmaceuticals they’re taking, and this trend continues in this study. While CBN is often marketed as “the sleep cannabinoid ,” the reality is more complicated.

Sleep 133

Sleep Data Tincture Research and Development 133

The Cannigma

AUGUST 26, 2021

The country legalized medical cannabis in 2016, but patients in the country have long criticized the program as too restrictive, and access to cannabis-based medicines remains behind that of many other legal cannabis jurisdictions. This also means that the TGA has not accessed these medicines for their safety, quality, or effectiveness.

Legalization 52

Legalization Access Medicine Clinical Trials 52